N/A
N=60
Evaluation of Various Methods Used to Identify the Proximal Humerus Intraosseous Vascular Access Site
Vascular Access
Bottom Line
View on ClinicalTrials.gov: NCT01742780 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Ease of Use Score — 9.60; 8.33; 8.60; 8.30 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Intraosseous Vascular Access (Other)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Vidacare Corporation
- Primary completion
- Dec 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Ease of Use Score |
9.60; 8.33; 8.60; 8.30 | — |
| PRIMARY Level of Confidence Score |
9.30; 7.22; 9.00; 8.00 | — |
| PRIMARY Proximal Humerus Intraosseous (IO) Insertion Site Placement Score |
1.9; 1.7; 1.4; 2.0 | — |
| PRIMARY Time to Intraosseous (IO) Catheter Placement |
116.6; 136.5; 121.0; 126.3 | — |
Summary
The purpose of this study is to determine if there is one method of identifying the proximal humerus intraosseous vascular access site that is easier for clinicians to use, out of the 4 methods being evaluated.
Eligibility Criteria
Inclusion Criteria Device Operators:
- Recent/current experience in the medical field as a practicing clinician.
- Currently licensed/certified Emergency Medicine Technician, paramedic, or nurse
- Have had no formal training on use of the proximal humerus intraosseous insertion site.
Exclusion Criteria Device Operators:
There is no exclusion criteria
Inclusion Criteria Healthy Volunteers
- Age 21 years or older.
- Has no amputation of the upper extremities.
- Able to lay flat on table for up to 2 hours.
- Self-reported as healthy.
Exclusion Criteria Healthy Volunteers:
- Have an active infection in the body
- Imprisoned
- Pregnant
- Cognitively impaired
- Fracture in humerus, or significant trauma to the site
- Excessive tissue and/or absence of adequate anatomical landmarks in humerus
- Infection in target area
- Humeral intraosseous insertion in past 48 hours, prosthetic limb or joint or other significant orthopedic procedure in humerus
- Current use of anti-coagulants
Data sourced from ClinicalTrials.gov (NCT01742780). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.